Dongguan HEC Biopharmaceutical R&D Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Dongguan HEC Biopharmaceutical R&D Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus (NCT06148649) | Dongguan HEC Biopharmaceutical R&D Co., Ltd. | 2023-12-10 |
| A Phase 1 Study of HEC88473 Injection in Healthy Subjects, Obese Subjects and T2DM Subjects (NCT05943886) | Dongguan HEC Biopharmaceutical R&D Co., Ltd. | 2021-08-11 |
| The Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy Subjects (NCT04829123) | Dongguan HEC Biopharmaceutical R&D Co., Ltd. | 2021-05-14 |
Track Dongguan HEC Biopharmaceutical R&D Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.